Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMTDavid Buchbinder, Bronwen E. Shaw, Debra Lynch Kelly et al.|Bone Marrow Transplantation|2018Cited by 104
A Recurrent De Novo Heterozygous COG4 Substitution Leads to Saul-Wilson Syndrome, Disrupted Vesicular Trafficking, and Altered Proteoglycan GlycosylationCarlos R. Ferreira, Andrew P. Jackson, Benjamin D. Solomon et al.|The American Journal of Human Genetics|2018Cited by 76
Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow TransplantationDebra Lynch Kelly, Bronwen E. Shaw, David Buchbinder et al.|Transplantation and Cellular Therapy|2017Cited by 65
Defining the clinical phenotype of Saul–Wilson syndromeCarlos R. Ferreira, Michael B. Bober, Wadih M. Zein et al.|Genetics in Medicine|2020Cited by 21
Comparable outcomes after busulfan- or treosulfan-based conditioning for allo-HSCT in children with ALL: results of FORUMKrzysztof Kałwak, Franco Locatelli, Laura M. Moser et al.|Blood Advances|2024Cited by 3